IMPACT OF RISANKIZUMAB ON INTESTINAL STENOSIS IN PATIENTS WITH MODERATELY TO SEVERELY ACTIVE CROHN’S DISEASE: POST HOC ANALYSIS OF THE PHASE 3 ADVANCE, MOTIVATE, AND FORTIFY STUDIES

Walter Reinisch  1     Florian Rieder  2     Vipul Jairath  3, 4     Makoto Sasaki  5     Kristina Kligys  6     Ezequiel Neimark  6     Javier Zambrano  6     Yafei Zhang  6     Jean-Frédéric Colombel  7    
1 Medical University of Vienna, Vienna, Austria
2 Cleveland Clinic, Cleveland, United States
3 University Hospital, London, Canada
4 Western University, London, Canada
5 Aichi Medical University School of Medicine, Nagakute, Japan
6 AbbVie Inc., North Chicago, United States
7 Icahn School of Medicine at Mount Sinai, New York, United States

Topic
Endoscopy, IBD

Conference
UEG Week 2023

Citation
United European Gastroenterology Journal 2023; 11 (Supplement 8)


Login to access library content

Login

Do you need help setting up your myUEG account?
Contact us at [email protected]

New to myUEG?

Create myUEG account

Social Sharing